| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |